Femasys Inc. (FEMY) vs GlucoTrack, Inc. (GCTK)

Femasys Inc. and GlucoTrack, Inc. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $20.4M against $1.9M — 11.0× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −534.3%) and the higher return on invested capital (0.00% vs −176.9%). Across the 17 metrics below, Femasys Inc. leads on 9 and GlucoTrack, Inc. on 8.

Valuation

Metric FEMY GCTK Medical Instruments & Supplies median
P/E n/m n/m 34.17
P/S 3.62 2.92 2.83
P/B 2.07 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 4.57 6.85 3.06
Earnings yield (142.34%) (7,562.14%) (1.84%)
Free cash flow yield (217.10%) (2,683.44%) 0.17%

Profitability

Metric FEMY GCTK Medical Instruments & Supplies median
Gross margin 60.95% 0.00% 54.62%
Operating margin (763.90%) 0.00% 1.64%
Net margin (534.27%) 0.00% 0.00%
Free cash flow margin (786.02%) 0.00% 1.61%
Return on equity (443.65%) (620.63%) 0.00%
Return on assets (94.25%) (272.48%) 0.00%
Return on invested capital (176.91%) 0.00% 0.00%

Growth

Metric FEMY GCTK Medical Instruments & Supplies median
Revenue growth (TTM) 21.85% (60.61%) 9.20%
EPS growth (last fiscal year) 44.71% 99.24% —
Revenue growth, 5-year CAGR 17.18% 28.31% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FEMY GCTK Medical Instruments & Supplies median
Debt to equity 0.90 (1.11) 0.08
Current ratio 2.14 0.46 2.49
Net debt to EBITDA 0.23 0.25 0.83

Dividend

Metric FEMY GCTK Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric FEMY GCTK Medical Instruments & Supplies median
Market cap 20.35m 1.85m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack